Ingersoll Rand (IR) Morgan Stanley‘s 12th Annual Laguna Conference summary
Event summary combining transcript, slides, and related documents.
Morgan Stanley‘s 12th Annual Laguna Conference summary
20 Jan, 2026Strategic approach and culture
Emphasizes an ownership mindset among 20,000+ employees, supported by equity participation and transparent strategic planning.
Utilizes a proprietary IRX tool to drive execution and performance.
Maintains a scalable, unified culture across all acquisitions, supporting rapid integration and growth.
M&A strategy and execution
Completed 51 acquisitions in 4.5 years, with 50 being bolt-on and 90% sole-sourced.
Conducts anchor acquisitions every 3–5 years, such as ILC Dover, to expand into new markets like life sciences.
Maintains a robust M&A funnel, with eight companies under LOI and a dedicated leader for life sciences.
Targets mid-teens ROIC by year three for bolt-on deals, focusing on financial discipline.
Life sciences expansion
ILC Dover acquisition increased addressable market by $10 billion and more than doubled the life sciences business.
Integration is progressing well, with early signs of revenue synergies and cross-selling opportunities.
Life sciences expected to grow to high teens or low twenties as a percentage of total revenue.
Latest events from Ingersoll Rand
- Recurring revenue and disciplined M&A drive growth, with strong margins and innovation focus.IR
Citi's Global Industrial Tech & Mobility Conference 202619 Feb 2026 - Recurring revenue surges and prudent growth drive strong margins and targeted M&A focus.IR
Barclays 43rd Annual Industrial Select Conference18 Feb 2026 - Strong 2025 growth, robust M&A, and steady 2026 outlook despite global challenges.IR
Q4 202513 Feb 2026 - Record Q2 results and raised 2024 guidance, driven by margin gains, M&A, and strong execution.IR
Q2 20242 Feb 2026 - Demand generation, digitalization, and M&A drive growth as legacy risks are eliminated.IR
Wells Fargo 2024 Industrials Conference1 Feb 2026 - Stable growth, active M&A, and expanding recurring revenue drive margin improvement.IR
Jefferies Global Industrial Conference 202422 Jan 2026 - Record Q3 results, strong margin expansion, and major acquisitions drive positive outlook.IR
Q3 202417 Jan 2026 - Disciplined M&A and life science expansion drive robust growth, margins, and value creation.IR
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026 - ILC Dover boosts life sciences, recurring revenue accelerates, and margins remain robust.IR
Goldman Sachs Industrials & Materials Conference11 Jan 2026